Hennion & Walsh Asset Management Inc. Sells 633 Shares of McKesson Corporation $MCK

Hennion & Walsh Asset Management Inc. lessened its holdings in shares of McKesson Corporation (NYSE:MCK) by 6.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,623 shares of the company’s stock after selling 633 shares during the period. Hennion & Walsh Asset Management Inc.’s holdings in McKesson were worth $7,894,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the business. GGM Financials LLC purchased a new stake in shares of McKesson in the third quarter worth approximately $25,000. State of Wyoming purchased a new position in McKesson during the 2nd quarter valued at $29,000. Hopwood Financial Services Inc. bought a new position in McKesson in the 3rd quarter valued at $31,000. Board of the Pension Protection Fund bought a new position in McKesson in the 4th quarter valued at $33,000. Finally, Vermillion & White Wealth Management Group LLC purchased a new stake in McKesson in the third quarter worth $33,000. Institutional investors own 85.07% of the company’s stock.

Insider Buying and Selling

In other McKesson news, EVP Leann B. Smith sold 190 shares of the stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total transaction of $179,550.00. Following the completion of the sale, the executive vice president directly owned 2,989 shares of the company’s stock, valued at approximately $2,824,605. This represents a 5.98% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Thomas L. Rodgers sold 276 shares of the firm’s stock in a transaction dated Monday, January 5th. The shares were sold at an average price of $816.18, for a total transaction of $225,265.68. Following the completion of the sale, the executive vice president owned 2,268 shares in the company, valued at $1,851,096.24. This represents a 10.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 3,868 shares of company stock valued at $3,743,820 over the last three months. Corporate insiders own 0.08% of the company’s stock.

McKesson Stock Up 0.0%

Shares of NYSE:MCK opened at $860.41 on Monday. The firm has a 50 day moving average of $907.62 and a 200 day moving average of $840.69. The company has a market capitalization of $105.39 billion, a price-to-earnings ratio of 24.75, a price-to-earnings-growth ratio of 1.38 and a beta of 0.38. McKesson Corporation has a 52 week low of $637.00 and a 52 week high of $999.00.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business had revenue of $106.16 billion for the quarter, compared to analysts’ expectations of $105.98 billion. During the same quarter last year, the firm earned $8.03 EPS. The business’s revenue for the quarter was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, sell-side analysts expect that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be given a dividend of $0.82 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. McKesson’s dividend payout ratio (DPR) is presently 9.43%.

Analysts Set New Price Targets

Several research firms have recently weighed in on MCK. Mizuho lifted their target price on McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a research report on Thursday, February 5th. Weiss Ratings downgraded shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a research note on Thursday, February 5th. JPMorgan Chase & Co. lifted their price objective on shares of McKesson from $983.00 to $1,107.00 and gave the company an “overweight” rating in a report on Tuesday, February 10th. Barclays boosted their price objective on shares of McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a research report on Wednesday, February 18th. Finally, Morgan Stanley restated an “overweight” rating and issued a $966.00 target price on shares of McKesson in a research note on Thursday, January 29th. Thirteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, McKesson presently has a consensus rating of “Moderate Buy” and an average price target of $960.93.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.